| Pharmaceutical active ingredients: |
| MethylprednisoloneWater |
| Available forms, composition and doses of Methylprednisolone: |
| Injectable; Injection; Methylprednisolone 1 g; Water 20 mlInjectable; Injection; Methylprednisolone 500 mg; Water 10 ml |
| Methylprednisolone medical category: |
| Human:AdrenalsAnti-inflammatory agentsCorticosteroid hormonesEye corticosteroidsOestrogens and progesterones and related synthetic drugsTopical corticosteroidsTreatment of dermatological diseasesWeak (group I) corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07AA01 - MethylprednisoloneD10AA02 - MethylprednisoloneH02AB04 - Methylprednisolone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Hospira |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Metypred | Methylprednisolone; Methylprednisolone Sodium Succinate | Galenpharma; Orion Pharma |
| Nayapred | Methylprednisolone; Methylprednisolone Sodium Succinate | BMW Pharmaco India |
| Solu-Cort | Methylprednisolone; Methylprednisolone Sodium Succinate | Venus Remedies |
| Thimelon | Methylprednisolone; Methylprednisolone Sodium Succinate | Ethica Industri Farmasi |
| Neo-Medrol | Methylprednisolone; Neomycin Sulfate | Pfizer; Perrigo; Zuellig Pharma |
| Aizen Crystal Violet Base | Methylrosaniline | Unidentified Pharmaceutical Company |
| Carbinolbase des Kristallviolett | Methylrosaniline | Unidentified Pharmaceutical Company |
| Vigencial | Methylrosanilinium Chloride | Estedi |
| Viogencianol | Methylrosanilinium Chloride | Aprofa |
| Dulciphak | Methylsilanetriol Sodium Salicylate; Para-Hydroxycinnamic Acid | Allergan |